Applications
Deadline for 2011 Conference Approaching
Since 2009 the top MedVentures finalists have raised more than $30
million. MedVentures is an early-stage investment conference which
showcases medical technology companies. This is a remarkable amount
of money considering all but one top presenter were pre-revenue
companies. To have a group with such collective success
demonstrates the caliber of companies chosen to present at
MedVentures.
One of the 2010
MedVentures top companies, Adapta Medical, Inc., made
exceptional strides with the help of investors. The developer of
several disposable medical devices received investment capital
while executing on significant milestones like receiving FDA
clearance and submitting additional patents. Additionally, a
significant cash infusion helped OrthoKinematics, Inc.
with preparing to launch products early next year. The staple of
success for most of the presenting companies was private capital
through angel and venture capital sources.
However, the fundraising success for some was a bit
non-traditional. Natural-Dental-Implant
AG is a German company with a U.S. subsidiary. The organization
raised funds here for a company proposing to do the development in
Europe. Those dollars came with German government matching funds, a
nice sweetener for the company's investors. Grants, SBA loans and
partnerships with strategic investors also played a role in the
fundraising successes.
Medventures 2011 is now accepting applications to present.
Deadline is 7/31/2011. No cost to apply or present if chosen.
• Application
Guidelines
• MedVentures 2011
Information
• MedVentures 2010
recap
Here are the 2010 top ten companies in alphabetic order:
Adapta Medical, Inc.
has developed several innovative disposable urological medical
devices for inpatient and outpatient applications reducing
catheterization time and infection rates.
Aequorea Vision Medical,
Inc. has developed technology which will allow for the
identification of cervical cancers caused by HPV and other cancers
in real time.
Heart Test Laboratories
Inc. has developed a proprietary patent pending device to
identify myocardial abnormalities-ischemia, which is reduced blood
flow to the heart muscle. This product can help in the early
detection of heart attacks.
Kewl Innovations,
Inc.'s small, lightweight Kewl device offers users an
untethered and rechargeable device which controls and monitors the
temperature of insulin on a single charge for up to three days in
various environments.
Magaw Medical, LLC
created the "CoPilot", a cost-effective and improved video
laryngoscope that will raise the airway management standard of
care.
Nanospectra Biosciences,
Inc. has developed "AuroLase Therapy", which may allow the
focal treatment of prostate cancer, treating only the tumor
affected areas and reducing the side effects associated with
current therapies
Natural Dental
Implants, AG has developed a non‐surgical tooth replacement
system that enables general dentists to replace teeth
non‐surgically in a single appointment, thus reducing the time,
cost and inconvenience associated with current techniques.
NetMed Care, Inc. is
creating NetMed Care eClinics, a branded service that will change
the way healthcare is delivered by creating access to quality
health care, at reduced costs, for multiple market segments through
a unique telemedicine solution.
OrthoKinematics,
Inc. has launched the "KineGraph VMA", a new functional test
for the spine that helps spine surgeons make better decisions to
improve their surgical outcomes.
Palmaz Scientific,
Inc. has developed proprietary nanotechnology based methods
that are providing a potential game changing technology platform
for the future of implantable medical devices.
Apply Now
to present at the MedVentures 2011 conference on October 6th
2011
follow hubert on twitter @hubertzajicek